Literature DB >> 24590509

T-type calcium channels in chronic pain: mouse models and specific blockers.

Amaury François1, Sophie Laffray, Anne Pizzoccaro, Alain Eschalier, Emmanuel Bourinet.   

Abstract

Pain is a quite frequent complaint accompanying numerous pathologies. Among these pathological cases, neuropathies are retrieved with identified etiologies (chemotherapies, diabetes, surgeries…) and also more diffuse syndromes such as fibromyalgia. More broadly, pain is one of the first consequences of the majority of inherited diseases. Despite its importance for the quality of life, current pain management is limited to drugs that are either old or with a limited efficacy or that possess a bad benefit/risk ratio. As no new pharmacological concept has led to new analgesics in the last decades, the discovery of medications is needed, and to this aim the identification of new druggable targets in pain transmission is a first step. Therefore, studies of ion channels in pain pathways are extremely active. This is particularly true with ion channels in peripheral sensory neurons in dorsal root ganglia (DRG) known now to express unique sets of these channels. Moreover, both spinal and supraspinal levels are clearly important in pain modulation. Among these ion channels, we and others revealed the important role of low voltage-gated calcium channels in cellular excitability in different steps of the pain pathways. These channels, by being activated nearby resting membrane potential have biophysical characteristics suited to facilitate action potential generation and rhythmicity. In this review, we will review the current knowledge on the role of these channels in the perception and modulation of pain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24590509     DOI: 10.1007/s00424-014-1484-4

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  134 in total

1.  Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels.

Authors:  D Kim; I Song; S Keum; T Lee; M J Jeong; S S Kim; M W McEnery; H S Shin
Journal:  Neuron       Date:  2001-07-19       Impact factor: 17.173

2.  Alternative splicing at C terminus of Ca(V)1.4 calcium channel modulates calcium-dependent inactivation, activation potential, and current density.

Authors:  Gregory Ming Yeong Tan; Dejie Yu; Juejin Wang; Tuck Wah Soong
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

3.  CACNA1H mutations in autism spectrum disorders.

Authors:  Igor Splawski; Dana S Yoo; Stephanie C Stotz; Allison Cherry; David E Clapham; Mark T Keating
Journal:  J Biol Chem       Date:  2006-06-05       Impact factor: 5.157

4.  Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels.

Authors:  Michael T Nelson; Jiwan Woo; Ho-Won Kang; Iuliia Vitko; Paula Q Barrett; Edward Perez-Reyes; Jung-Ha Lee; Hee-Sup Shin; Slobodan M Todorovic
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

5.  A TRP channel that senses cold stimuli and menthol.

Authors:  Andrea M Peier; Aziz Moqrich; Anne C Hergarden; Alison J Reeve; David A Andersson; Gina M Story; Taryn J Earley; Ilaria Dragoni; Peter McIntyre; Stuart Bevan; Ardem Patapoutian
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

6.  Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy.

Authors:  Sarah J L Flatters; Gary J Bennett
Journal:  Pain       Date:  2004-05       Impact factor: 6.961

Review 7.  Moving from an averaged to specific view of spinal cord pain processing circuits.

Authors:  B A Graham; A M Brichta; R J Callister
Journal:  J Neurophysiol       Date:  2007-06-13       Impact factor: 2.714

8.  Spontaneous neuronal hyperactivity in the medial and intralaminar thalamic nuclei of patients with deafferentation pain.

Authors:  P C Rinaldi; R F Young; D Albe-Fessard; J Chodakiewitz
Journal:  J Neurosurg       Date:  1991-03       Impact factor: 5.115

9.  Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability.

Authors:  Matthew S Grubb; Juan Burrone
Journal:  Nature       Date:  2010-06-13       Impact factor: 49.962

10.  Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice.

Authors:  Janelle R Latham; Sriyani Pathirathna; Miljen M Jagodic; Won Joo Choe; Michaela E Levin; Michael T Nelson; Woo Yong Lee; Kathiresan Krishnan; Douglas F Covey; Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more
  17 in total

1.  Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop.

Authors:  Arnaud Monteil; Patrick Chausson; Katia Boutourlinsky; Alexandre Mezghrani; Sylvaine Huc-Brandt; Iulia Blesneac; Isabelle Bidaud; Céline Lemmers; Nathalie Leresche; Régis C Lambert; Philippe Lory
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

2.  Selective inhibition of CaV3.2 channels reverses hyperexcitability of peripheral nociceptors and alleviates postsurgical pain.

Authors:  Sonja L Joksimovic; Srdjan M Joksimovic; Vesna Tesic; Agustin García-Caballero; Simon Feseha; Gerald W Zamponi; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  Sci Signal       Date:  2018-08-28       Impact factor: 8.192

3.  Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain.

Authors:  Saïd M'Dahoma; Vinicius M Gadotti; Fang-Xiong Zhang; Byeongyeon Park; Ji Hye Nam; Valentina Onnis; Gianfranco Balboni; Jae Yeol Lee; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2015-09-10       Impact factor: 3.657

4.  Inhibition of human N- and T-type calcium channels by an ortho-phenoxyanilide derivative, MONIRO-1.

Authors:  Jeffrey R McArthur; Leonid Motin; Ellen C Gleeson; Sandro Spiller; Richard J Lewis; Peter J Duggan; Kellie L Tuck; David J Adams
Journal:  Br J Pharmacol       Date:  2017-07-21       Impact factor: 8.739

5.  Modulation of Cav3.2 T-type calcium channel permeability by asparagine-linked glycosylation.

Authors:  Katarina Ondacova; Maria Karmazinova; Joanna Lazniewska; Norbert Weiss; Lubica Lacinova
Journal:  Channels (Austin)       Date:  2016-01-08       Impact factor: 2.581

6.  Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries.

Authors:  Osama F Harraz; Rasha R Abd El-Rahman; Kamran Bigdely-Shamloo; Sean M Wilson; Suzanne E Brett; Monica Romero; Albert L Gonzales; Scott Earley; Edward J Vigmond; Anders Nygren; Bijoy K Menon; Rania E Mufti; Tim Watson; Yves Starreveld; Tobias Furstenhaupt; Philip R Muellerleile; David T Kurjiaka; Barry D Kyle; Andrew P Braun; Donald G Welsh
Journal:  Circ Res       Date:  2014-08-01       Impact factor: 17.367

Review 7.  Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: emerging controversies concerning the role of H2 S in nociception.

Authors:  Jacobo Elies; Jason L Scragg; John P Boyle; Nikita Gamper; Chris Peers
Journal:  J Physiol       Date:  2016-02-25       Impact factor: 5.182

Review 8.  The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Authors:  Gerald W Zamponi; Joerg Striessnig; Alexandra Koschak; Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

9.  Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5).

Authors:  Aida Calderón-Rivera; Alejandro Sandoval; Ricardo González-Ramírez; Christian González-Billault; Ricardo Felix
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

10.  Inflammatory mediator bradykinin increases population of sensory neurons expressing functional T-type Ca(2+) channels.

Authors:  Dongyang Huang; Ce Liang; Fan Zhang; Hongchao Men; Xiaona Du; Nikita Gamper; Hailin Zhang
Journal:  Biochem Biophys Res Commun       Date:  2016-03-02       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.